Immunomodulation in sepsis: The role of endotoxin removal by polymyxin B-immobilized cartridge

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Esteban, Elisabeth ^a   Ferrer, Ricard ^b   Alsina, Laia ^a   Artigas, Antonio ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL MÚTUA DE TERRASSA   (Spain)

^c HOSPITAL DE SABADELL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ENDOTOXIN; ERYTHROPOIETIN; GELATINASE B; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; LEUKOCYTE ELASTASE; METALLOPROTEINASE; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMYXIN B; POROUS POLYMER; TOLL LIKE RECEPTOR 4; TORAYMYXIN 20R; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; CYTOKINE; HMGB1 PROTEIN, HUMAN; LIPOPOLYSACCHARIDE;

ACUTE LUNG INJURY; ACUTE RESPIRATORY FAILURE; ADSORPTION; ADULT RESPIRATORY DISTRESS SYNDROME; CD4+ CD25+ T LYMPHOCYTE; CLINICAL TRIAL (TOPIC); DEVICE SAFETY; DRUG EFFICACY; DRUG SAFETY; FIBER; FILTRATION; GLYCATION; GRAM NEGATIVE SEPSIS; HEMOFILTRATION; HEMOPERFUSION; HUMAN; IMMUNOMODULATION; INFLAMMATION; INTERSTITIAL PNEUMONIA; LYMPHOCYTE; MEDICAL DEVICE; MEMBRANE FILTER; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY T LYMPHOCYTE; RESPIRATORY FAILURE; REVIEW; SEPSIS; SEPTIC SHOCK; SYSTEMATIC REVIEW (TOPIC); THERMODYNAMICS; BLOOD; CHEMISTRY; EQUIPMENT DESIGN; IMMUNE SYSTEM; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; PHENOTYPE;

NEGIBACTERIA;

ADSORPTION; CYTOKINES; ENDOTOXINS; EQUIPMENT DESIGN; HMGB1 PROTEIN; HUMANS; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; LIPOPOLYSACCHARIDES; PHENOTYPE; POLYMYXIN B; SEPSIS;

EID: 84887385150     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/507539     Document Type: Review

References (103)

1. Angus D. C., Linde-Zwirble W. T., Lidicker J., Clermont G., Carcillo J., Pinsky M. R., Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine 2001 29 7 1303 1310 2-s2.0-0034958947 (Pubitemid 32641789)
2. Dombrovskiy V. Y., Martin A. A., Sunderram J., Paz H. L., Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Critical Care Medicine 2007 35 5 1244 1250 2-s2.0-34247338128 10.1097/01.CCM.0000261890.41311.E9 (Pubitemid 46642649)
3. Kissoon N., Carcillo J. A., Espinosa V., Argent A., Devictor D., Madden M., Singhi S., Van Der Voort E., Latour J., World federation of pediatric intensive care and critical care societies: global sepsis initiative. Pediatric Critical Care Medicine 2011 12 5 494 503 2-s2.0-80455132371 10.1097/PCC. 0b013e318207096c
4. Dellinger R. P., Levy M. M., Rhodes A., Annane D., Gerlach H., Opal S. M., Sevransky J. E., Sprung C. L., Douglas I. S., Jaeschke R., Osborn T. M., Nunnally M. E., Townsend S. R., Reinhart K., Kleinpell R. M., Angus D. C., Deutschman C. S., Machado F. R., Rubenfeld G. D., Webb S., Beale R. J., Vincent J. L., Moreno R., Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Medicine 2013 39 165 228
5. Ferrer R., Artigas A., Levy M. M., Blanco J., González-Díaz G., Garnacho-Montero J., Ibáñez J., Palencia E., Quintana M., De La Torre-Prados M. V., Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. Journal of the American Medical Association 2008 299 19 2294 2303 2-s2.0-44249118788 10.1001/jama.299.19.2294 (Pubitemid 351724396)
6. Levy M. M., Dellinger R. P., Townsend S. R., Linde-Zwirble W. T., Marshall J. C., Bion J., Schorr C., Artigas A., Ramsay G., Beale R., Parker M. M., Gerlach H., Reinhart K., Silva E., Harvey M., Regan S., Angus D. C., The surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Critical Care Medicine 2010 38 2 367 374 2-s2.0-74949116220 10.1097/CCM.0b013e3181cb0cdc
7. Esteban A., Frutos-Vivar F., Ferguson N. D., Peñuelas O., Lorente J. Á., Gordo F., Honrubia T., Algora A., Bustos A., García G., Diaz-Regañón I. R., De Luna R. R., Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Critical Care Medicine 2007 35 5 1284 1289 2-s2.0-34247392485 10.1097/01.CCM.0000260960.94300. DE (Pubitemid 46642655)
8. Martin G. S., Mannino D. M., Eaton S., Moss M., The epidemiology of sepsis in the United States from 1979 through 2000. The New England Journal of Medicine 2003 348 16 1546 1554 2-s2.0-0037451929 10.1056/NEJMoa022139 (Pubitemid 36437931)
9. Akira S., Uematsu S., Takeuchi O., Pathogen recognition and innate immunity. Cell 2006 124 4 783 801 2-s2.0-32944464648 10.1016/j.cell.2006.02.015 (Pubitemid 43261452)
10. Opal S. M., The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. International Journal of Medical Microbiology 2007 297 5 365 377 2-s2.0-34547515353 10.1016/j.ijmm.2007. 03.006 (Pubitemid 47188050)
11. Da Silva A. M. T., Kaulbach H. C., Chuidian F. S., Lambert D. R., Suffredini A. F., Danner R. L., Brief report: shock and multiple-organ dysfunction after self- administration of salmonella endotoxin. The New England Journal of Medicine 1993 328 20 1457 1461 2-s2.0-0027210486 10.1056/ NEJM199305203282005 (Pubitemid 23143848)
12. McCloskey R. V., Straube R. C., Sanders C., Smith S. M., Smith C. R., Treatment of septic shock with human monoclonal antibody HA-1A: a randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine 1994 121 1 1 5 2-s2.0-0028557981
13. Angus D. C., Birmingham M. C., Balk R. A., Scannon P. J., Collins D., Kruse J. A., Graham D. R., Dedhia H. V., Homann S., Macintyre N., E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. Journal of the American Medical Association 2000 283 13 1723 1730 2-s2.0-0034607323 (Pubitemid 30196213)
14. Dellinger P. R., Tomayko J. F., Angus D. C., Opal S., Cupo M. A., McDermott S., Ducher A., Calandra T., Cohen J., Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial. Critical Care Medicine 2009 37 11 2929 2938 2-s2.0-73449108032 10.1097/CCM.0b013e3181b0266c
15. Tidswell M., Tillis W., Larosa S. P., Lynn M., Wittek A. E., Kao R., Wheeler J., Gogate J., Opal S. M., Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis. Critical Care Medicine 2010 38 1 72 83 2-s2.0-74049125175 10.1097/CCM. 0b013e3181b07b78
16. Zhou F., Peng Z., Murugan R., Kellum J. A., Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Critical Care Medicine 2013 41 9 2209 2220 10.1097/CCM.0b013e31828cf412
17. Taniguchi T., Sato K., Kurita A., Noda T., Okajima M., Efficacy of endotoxin adsorption therapy (polymyxin B hemoperfusion) for methicillin-resistant Staphylococcus aureus toxic shock syndrome. A case report about five patients. Minerva Anestesiologica 2013 79 7 758 761
18. Abe S., Azuma A., Mukae H., Ogura T., Taniguchi H., Bando M., Sugiyama Y., Polymyxin B-immobilized fiber column (PMX) treatment for idiopathic pulmonary fibrosis with acute exacerbation: a multicenter retrospective analysis. Internal Medicine 2012 51 1487 1491
19. Enomoto N., Suda T., Uto T., Kato M., Kaida Y., Ozawa Y., Miyazaki H., Kuroishi S., Hashimoto D., Naito T., Fujisawa T., Matsui T., Inui N., Nakamura Y., Sato J., Mizuguchi T., Kato A., Chida K., Possible therapeutic effect of direct haemoperfusion with a polymyxin B immobilized fibre column (PMX-DHP) on pulmonary oxygenation in acute exacerbations of interstitial pneumonia. Respirology 2008 13 3 452 460 2-s2.0-41849111288 10.1111/j.1440-1843.2008.01290. x (Pubitemid 351503154)
20. Hara S., Ishimoto H., Sakamoto N., Mukae H., Kakugawa T., Ishimatsu Y., Mine M., Kohno S., Direct hemoperfusion using immobilized polymyxin B in patients with rapidly progressive interstitial pneumonias: a retrospective study. Respiration 2011 81 2 107 117 2-s2.0-79951675231 10.1159/000321958
21. Nakamura T., Ushiyama C., Suzuki Y., Inoue T., Shoji H., Shimada N., Koide H., Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillin-resistant Staphylococcus aureus. Journal of Hospital Infection 2003 53 1 58 63 2-s2.0-0346142713 10.1053/jhin.2002.1332 (Pubitemid 38002089)
22. Winchester J. F., Kellum J. A., Ronco C., Brady J. A., Quartararo P. J., Salsberg J. A., Levin N. W., Sorbents in acute renal failure and the systemic inflammatory response syndrome. Blood Purification 2003 21 1 79 84 2-s2.0-0037261748 10.1159/000067860 (Pubitemid 36173353)
23. Li J., Nation R. L., Turnidge J. D., Milne R. W., Coulthard K., Rayner C. R., Paterson D. L., Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. The Lancet Infectious Diseases 2006 6 9 589 601 2-s2.0-33747362870 10.1016/S1473-3099(06)70580-1
24. Cruz D. N., Antonelli M., Fumagalli R., Foltran F., Brienza N., Donati A., Malcangi V., Petrini F., Volta G., Bobbio Pallavicini F. M., Rottoli F., Giunta F., Ronco C., Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. Journal of the American Medical Association 2009 301 23 2445 2452 2-s2.0-67649219652 10.1001/jama.2009.856
25. Vincent J.-L., Laterre P.-F., Cohen J., Burchardi H., Bruining H., Lerma F. A., Wittebole X., De Backer D., Brett S., Marzo D., Nakamura H., John S., A pilot-controlled study of a polymyxim B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005 23 5 400 405 2-s2.0-20244379132 10.1097/01.shk.0000159930.87737.8a (Pubitemid 40571661)
26. Hirabayashi K., Shiohara M., Saito S., Tanaka M., Yanagisawa R., Tsuruta G., Fukuyama T., Hidaka Y., Nakazawa Y., Shimizu T., Sakashita K., Koike K., Polymyxin-direct hemoperfusion for sepsis-induced multiple organ failure. Pediatric Blood and Cancer 2010 55 1 202 205 2-s2.0-77953235612 10.1002/pbc.22447
27. Kulabukhov V. V., Use of an endotoxin adsorber in the treatment of severe abdominal sepsis. Acta Anaesthesiologica Scandinavica 2008 52 7 1024 1025 2-s2.0-46749152960 10.1111/j.1399-6576.2008.01677.x (Pubitemid 351951775)
28. Yaroustovsky M., Abramyan M., Popok Z., Nazarova E., Stupchenko O., Popov D., Plushch M., Samsonova N., Preliminary report regarding the use of selective sorbents in complex cardiac surgery patients with extensive sepsis and prolonged intensive care stay. Blood Purification 2009 28 3 227 233 2-s2.0-68549135271 10.1159/000231988
29. Ala-Kokko T. I., Laurila J., Koskenkari J., A new endotoxin adsorber in septic shock: observational case series. Blood Purification 2011 32 4 303 309 2-s2.0-80052305155 10.1159/000330323
30. Rimmelé T., Assadi A., Cattenoz M., Desebbe O., Lambert C., Boselli E., Goudable J., Étienne J., Chassard D., Bricca G., Allaouchiche B., High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs. Nephrology Dialysis Transplantation 2009 24 2 421 427 2-s2.0-58449111911 10.1093/ndt/gfn518
31. Shum H. P., Chan K. C., Kwan M. C., Yan W. W., Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram-negative bacterial infection. Hong Kong Medical Journal 2013 10.12809/hkmj133910
32. Honore P. M., Jacobs R., Joannes-Boyau O., De R. J., De W. E., van V G., Boer W., Verfaillie L., Spapen H. D., Newly designed CRRT membranes for sepsis and SIRS-a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review. ASAIO Journal 2013 59 99 106
33. Reinhart K., Meier-Hellmann A., Beale R., Forst H., Boehm D., Willatts S., Rothe K. F., Adolph M., Hoffmann J. E., Boehme M., Bredle D. L., Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis. Critical Care Medicine 2004 32 8 1662 1668 2-s2.0-3943092597 10.1097/01.CCM.0000132902.54925.B5 (Pubitemid 39050515)
34. Ronco C., Brendolan A., Lonnemann G., Bellomo R., Piccinni P., Digito A., Dan M., Irone M., La Greca G., Inguaggiato P., Maggiore U., De Nitti C., Wratten M. L., Ricci Z., Tetta C., A pilot study of coupled plasma filtration with adsorption in septic shock. Critical Care Medicine 2002 30 6 1250 1255 2-s2.0-0036270678 (Pubitemid 34620967)
35. Mao H.-J., Yu S., Yu X.-B., Zhang B., Zhang L., Xu X.-R., Wang X.-Y., Xing C.-Y., Effects of coupled plasma filtration adsorption on immune function of patients with multiple organ dysfunction syndrome. International Journal of Artificial Organs 2009 32 1 31 38 2-s2.0-64849109417
36. Formica M., Olivieri C., Livigni S., Cesano G., Vallero A., Maio M., Tetta C., Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock. Intensive Care Medicine 2003 29 5 703 708 2-s2.0-0038631889 (Pubitemid 36609560)
37. ClinicalTrials.gov.COMbining Plasma-filtration and Adsorption Clinical Trial 2 (COMPACT2). NCT01639664. 2013, http://clinicaltrials.gov/ct2/show/ NCT01639664
38. Peng Z.-Y., Carter M. J., Kellum J. A., Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Critical Care Medicine 2008 36 5 1573 1577 2-s2.0-42949146538 10.1097/CCM.0b013e318170b9a7 (Pubitemid 351620670)
39. Kellum J. A., Song M., Venkataraman R., Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor- B DNA binding, and improves short-term survival in lethal endotoxemia. Critical Care Medicine 2004 32 3 801 805 2-s2.0-1542719614 10.1097/01.CCM.0000114997. 39857.69 (Pubitemid 38340080)
40. van der Poll T., Opal S. M., Host-pathogen interactions in sepsis. The Lancet Infectious Diseases 2008 8 1 32 43 2-s2.0-39149097579 10.1016/S1473-3099(07)70265-7
41. Takeda K., Evolution and integration of innate immune recognition systems: the Toll-like receptors. Journal of Endotoxin Research 2005 11 1 51 55 2-s2.0-17344370677 10.1179/096805105225006687 (Pubitemid 40533080)
42. Cohen J., The immunopathogenesis of sepsis. Nature 2002 420 6917 885 891 2-s2.0-0037180768 10.1038/nature01326 (Pubitemid 36019643)
43. Opal S. M., Scannon P. J., Vincent J.-L., White M., Carroll S. F., Palardy J. E., Parejo N. A., Pribble J. P., Lemke J. H., Relationship between plasma levels of lipopolysaccharide (LPS) and LPS- binding protein in patients with severe sepsis and septic shock. Journal of Infectious Diseases 1999 180 5 1584 1589 2-s2.0-0032754358 10.1086/315093 (Pubitemid 29506461)
44. Marshall J. C., Foster D., Vincent J.-L., Cook D. J., Cohen J., Dellinger R. P., Opal S., Abraham E., Brett S. J., Smith T., Mehta S., Derzko A., Romaschin A., Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. Journal of Infectious Diseases 2004 190 3 527 534 2-s2.0-3042785468 10.1086/422254 (Pubitemid 38982092)
45. Niebauer J., Volk H.-D., Kemp M., Dominguez M., Schumann R. R., Rauchhaus M., Poole-Wilson P. A., Andrew J., Coats S., Anker S. D., Endotoxin and immune activation in chronic heart failure: a prospective cohort study. The Lancet 1999 353 9167 1838 1842 2-s2.0-0033614672 10.1016/S0140-6736(98)09286-1 (Pubitemid 29251016)
46. Lin C.-Y., Tsai I.-F., Ho Y.-P., Huang C.-T., Lin Y.-C., Lin C.-J., Tseng S.-C., Lin W.-P., Chen W.-T., Sheen I.-S., Endotoxemia contributes to the immune paralysis in patients with cirrhosis. Journal of Hepatology 2007 46 5 816 826 2-s2.0-34047149304 10.1016/j.jhep.2006.12.018 (Pubitemid 46529044)
47. Gonçalves S., Pecoits-Filho R., Perreto S., Barberato S. H., Stinghen A. E. M., Lima E. G. A., Fuerbringer R., Sauthier S. M., Riella M. C., Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients. Nephrology Dialysis Transplantation 2006 21 10 2788 2794 2-s2.0-33749631245 10.1093/ndt/gfl273 (Pubitemid 44542232)
48. Pathan N., Burmester M., Adamovic T., Berk M., Ng K. W., Betts H., Macrae D., Waddell S., Paul-Clark M., Nuamah R., Mein C., Levin M., Montana G., Mitchell J. A., Intestinal injury and endotoxemia in children undergoing surgery for congenital heart disease. American Journal of Respiratory and Critical Care Medicine 2011 184 11 1261 1269 2-s2.0-82555192163 10.1164/rccm.201104-0715OC
49. Clark J. A., Coopersmith C. M., Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness. Shock 2007 28 4 384 393 2-s2.0-34548682085 10.1097/shk.0b013e31805569df (Pubitemid 47421846)
50. Cinel I., Dellinger R. P., Advances in pathogenesis and management of sepsis. Current Opinion in Infectious Diseases 2007 20 4 345 352 2-s2.0-34347397197 10.1097/QCO.0b013e32818be70a (Pubitemid 47026230)
51. Vesentini S., Soncini M., Zaupa A., Silvestri V., Fiore G. B., Redaelli A., Multi-scale analysis of the Toraymyxin adsorption cartridge part 1: molecular interaction of polymyxin B with endotoxins. International Journal of Artificial Organs 2006 29 2 239 250 2-s2.0-33645799681
52. Nakamura T., Ebihara I., Shoji H., Ushiyama C., Suzuki S., Koide H., Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: decrease in plasma levels of soluble P-selectin, platelet factor 4 and β -thromboglobulin. Inflammation Research 1999 48 4 171 175 2-s2.0-0032929237 10.1007/s000110050442 (Pubitemid 29192518)
53. Suzuki H., Nemoto H., Nakamoto H., Okada H., Sugahara S., Kanno Y., Moriwaki K., Continuous hemodiafiltration with polymyxin-B immobilized fiber is effective in patients with sepsis syndrome and acute renal failue. Therapeutic Apheresis 2002 6 3 234 240 2-s2.0-0036317720 10.1046/j.1526-0968.2002.00416.x (Pubitemid 34753568)
54. Tani T., Hanasawa K., Kodama M., Imaizumi H., Yonekawa M., Saito M., Ikeda T., Yagi Y., Takayama K., Amano I., Shimaoka H., Ohta M., Okahisa T., Koga N., Fujita N., Yamasa H., Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients. World Journal of Surgery 2001 25 5 660 668 2-s2.0-17744380399 10.1007/s002680020028 (Pubitemid 32441443)
55. Ikeda T., Ikeda K., Nagura M., Taniuchi H., Matsushita M., Kiuchi S., Kuroki Y., Suzuki K., Matsuno N., Clinical evaluation of PMX-DHP for hypercytokinemia caused by septic multiple organ failure. Therapeutic Apheresis and Dialysis 2004 8 4 293 298 2-s2.0-4243066298 10.1111/j.1526-0968.2004.00167.x (Pubitemid 39108746)
56. Ono S., Tsujimoto H., Matsumoto A., Ikuta S.-I., Kinoshita M., Mochizuki H., Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber. American Journal of Surgery 2004 188 2 150 156 2-s2.0-3142658013 10.1016/j.amjsurg.2003.12.067 (Pubitemid 38916733)
57. Mitaka C., Tsuchida N., Kawada K., Nakajima Y., Imai T., Sasaki S., A Longer duration of polymyxin b-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock. Shock 2009 32 5 478 483 2-s2.0-70350217935 10.1097/SHK.0b013e3181a2a978
58. Novelli G., Ferretti G., Poli L., Pretagostini R., Ruberto F., Perrella S. M., Levi S., Morabito V., Berloco P. B., Clinical results of treatment of postsurgical endotoxin-mediated sepsis with polymyxin-B direct hemoperfusion. Transplantation Proceedings 2010 42 4 1021 1024 2-s2.0-79954464585 10.1016/j.transproceed.2010.03.056
59. Nemoto H., Nakamoto H., Okada H., Sugahara S., Moriwaki K., Arai M., Kanno Y., Suzuki H., Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purification 2001 19 4 361 369 2-s2.0-0035742403 10.1159/000046966 (Pubitemid 34701465)
60. Navarro R., Guerrero M., Gonzalez M., Quecedo L., Garcia A., Ramasco F., Description of the hemodynamic and respiratory effects of hemoperfusion treatment with polymyxin B in patients with abdominal septic shock. Revista Española de Anestesiología y Reanimación 2013 60 344 347
61. Kushi H., Miki T., Okamaoto K., Nakahara J., Saito T., Tanjoh K., Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Critical Care 2005 9 6 R653 R661 2-s2.0-31744448362
62. Nakamura T., Kawagoe Y., Matsuda T., Shoji H., Ueda Y., Tamura N., Ebiharad I., Koide H., Effect of polymyxin B-immobilized fiber on blood metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in acute respiratory distress syndrome patients. Blood Purification 2004 22 3 256 260 2-s2.0-4444255141 10.1159/000078494 (Pubitemid 39177729)
63. Nakamura T., Sato E., Fujiwara N., Kawagoe Y., Maeda S., Yamagishi S.-I., Suppression of high-mobility group box-1 and receptor for advanced glycation end-product axis by polymyxin B-immobilized fiber hemoperfusion in septic shock patients. Journal of Critical Care 2011 26 6 546 549 2-s2.0-80052964021 10.1016/j.jcrc.2010.11.010
64. Kojika M., Sato N., Yaegashi Y., Suzuki Y., Suzuki K., Nakae H., Endo S., Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity. Therapeutic Apheresis and Dialysis 2006 10 1 12 18 2-s2.0-33644973257 10.1111/j.1744-9987.2006.00340.x
65. Cruz D. N., Perazella M. A., Bellomo R., de Cal M., Polanco N., Corradi V., Lentini P., Nalesso F., Ueno T., Ranieri V. M., Ronco C., Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Critical Care 2007 11, article R47 2-s2.0-34249296716 10.1186/cc5780 (Pubitemid 46805281)
66. ClinicalTrials.gov. Safety and Efficacy of Polymyxin B Hemoperfusion, (PMX) for Septic Shock.EUPHRATES.NCT01046669. 2013, http://clinicaltrials.gov/ ct2/show/NCT01046669
67. ClinicalTrials.gov. Effects of hemoperfusion with a Polymyxin B membrane in peritonitis with septic shock (ABDO-MIX). NCT01222663. 2013, http://clinicaltrials.gov/ct2/show/NCT01222663
68. Ueno T., Ikeda T., Ikeda K., Taniuchi H., Suda S., Yeung M. Y., Matsuno N., HMGB-1 as a useful prognostic biomarker in sepsis-induced organ failure in patients undergoing PMX-DHP. Journal of Surgical Research 2011 171 1 183 190 2-s2.0-80054704092 10.1016/j.jss.2009.11.708
69. Oishi K., Mimura-Kimura Y., Miyasho T., Aoe K., Ogata Y., Katayama H., Murata Y., Ueoka H., Matsumoto T., Mimura Y., Association between cytokine removal by polymyxin B hemoperfusion and improved pulmonary oxygenation in patients with acute exacerbation of idiopathic pulmonary fibrosis. Cytokine 2013 61 84 89
70. Nakamura T., Ebihara I., Shimada N., Koide H., Changes in plasma erythropoietin and interleukin-6 concentrations in patients with septic shock after hemoperfusion with polymyxin B-immobilized fiber. Intensive Care Medicine 1998 24 12 1272 1276 2-s2.0-0031674255 10.1007/s001340050761 (Pubitemid 28564449)
71. Kushi H., Miki T., Nakahara J., Okamoto K., Saito T., Tanjoh K., Hemoperfusion with an immobilized polymyxin B column reduces the blood level of neutrophil elastase. Blood Purification 2006 24 2 212 217 2-s2.0-32944464362 10.1159/000090593 (Pubitemid 43259176)
72. Zagli G., Bonizzoli M., Spina R., Cianchi G., Pasquini A., Anichini V., Matano S., Tarantini F., Filippo A. D., Maggi E., Peris A., Effects of hemoperfusion with an immobilized polymyxin-B fiber column on cytokine plasma levels in patients with abdominal sepsis. Minerva Anestesiologica 2010 76 6 405 412 2-s2.0-77954966348
73. Gibot S., Massin F., Cravoisy A., Barraud D., Nace L., Levy B., Bollaert P.-E., High-mobility group box 1 protein plasma concentrations during septic shock. Intensive Care Medicine 2007 33 8 1347 1353 2-s2.0-34547094102 10.1007/s00134-007-0691-2 (Pubitemid 47101699)
74. Abe S., Hayashi H., Seo Y., Matsuda K., Kamio K., Saito Y., Usuki J., Azuma A., Kudo S., Gemma A., Reduction in serum high mobility group box-1 level by polymyxin b-immobilized fiber column in patients with idiopathic pulmonary fibrosis with acute exacerbation. Blood Purification 2011 32 4 310 316 2-s2.0-80052314344 10.1159/000330325
75. Ebihara I., Hirayama K., Nagai M., Kakita T., Sakai K., Tajima R., Sato C., Kurosawa H., Togashi A., Okada A., Usui J., Yamagata K., Kobayashi M., Angiopoietin balance in septic shock patients with acute lung injury: effect of direct hemoperfusion with polymyxin B-immobilized fiber. Therapeutic Apheresis and Dialysis 2011 15 4 349 354 2-s2.0-80051965073 10.1111/j.1744-9987.2011. 00963.x
76. Voelkel N. F., Vandivier R. W., Tuder R. M., Vascular endothelial growth factor in the lung. American Journal of Physiology 2006 290 2 L209 L221 2-s2.0-33644841513 10.1152/ajplung.00185.2005
77. Wang Y., Liu Y., Sarker K. P., Nakashima M., Serizawa T., Kishida A., Akashi M., Nakata M., Kitajima I., Maruyama I., Polymyxin B binds to anandamide and inhibits its cytotoxic effect. FEBS Letters 2000 470 2 151 155 2-s2.0-0034708407 10.1016/S0014-5793(00)01313-2 (Pubitemid 30151087)
78. Kohro S., Imaizumi H., Yamakage M., Masuda Y., Namiki A., Asai Y., Maruyama I., Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis. Journal of Anesthesia 2006 20 1 11 16 2-s2.0-31144434923 10.1007/s00540-005-0366-5 (Pubitemid 43125774)
79. Nakamura T., Kawagoe Y., Matsuda T., Koide H., Effect of polymyxin B-immobilized fiber on bone resorption in patients with sepsis. Intensive Care Medicine 2004 30 9 1838 1841 2-s2.0-4644275722 10.1007/s00134-004-2357-7 (Pubitemid 39297191)
80. Nakamura T., Ushiyama C., Shoji H., Koide H., Effects of hemoperfusion on serum cardiac troponin T concentrations using polymyxin B-immobilized fibers in septic patients undergoing hemodialysis. ASAIO Journal 2002 48 1 41 44 2-s2.0-0036265338 (Pubitemid 34575768)
81. Rimmele T., Kaynar A. M., McLaughlin J. N., Bishop J. V., Fedorchak M. V., Chuasuwan A., Peng Z., Singbartl K., Frederick D. R., Zhu L., Carter M., Federspiel W. J., Zeevi A., Kellum J. A., Leukocyte capture and modulation of cell-mediated immunity during human sepsis: an ex vivo study. Critical Care 2013 17 article R59
82. Kumagai T., Takeyama N., Yabuki T., Harada M., Miki Y., Kanou H., Inoue S., Nakagawa T., Noguchi H., Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock. Shock 2010 34 5 461 466 2-s2.0-78149280955 10.1097/SHK.0b013e3181e14ca0
83. Nishibori M., Takahashi H. K., Katayama H., Mori S., Saito S., Iwagaki H., Tanakac N., Morita K., Ohtsuka A., Specific removal of monocytes from peripheral blood of septic patients by polymyxin B-immobilized filter column. Acta Medica Okayama 2009 63 1 65 69 2-s2.0-62249218216
84. Boomer J. S., To K., Chang K. C., Takasu O., Osborne D. F., Walton A. H., Bricker T. L., Jarman S. D. II, Kreisel D., Krupnick A. S., Srivastava A., Swanson P. E., Green J. M., Hotchkiss R. S., Immunosuppression in patients who die of sepsis and multiple organ failure. Journal of the American Medical Association 2011 306 23 2594 2605 2-s2.0-84255194001 10.1001/jama.2011.1829
85. Bosmann M., Ward P. A., The inflammatory response in sepsis. Trends in Immunology 2013 34 129 136
86. Leentjens J., Kox M., van der Hoeven J. G., Netea M. G., Pickkers P., Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change? American Journal of Respiratory and Critical Care Medicine 2013 187 1287 1293
87. Cappelli C., López X., Labra Y., Montoya M., Fernández R., Imarai M., Rojas J. L., Miranda D., Escobar A., Acuña-Castillo C., Polymyxin B increases the depletion of T regulatory cell induced by purinergic agonist. Immunobiology 2012 217 3 307 315 2-s2.0-84856484977 10.1016/j.imbio.2011.10.006
88. + regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers. Surgery 2013 153 2 262 271 10.1016/j.surg.2012.06.023
89. Takeda S., Munakata R., Abe S., Mii S., Suzuki M., Kashiwada T., Azuma A., Yamamoto T., Gemma A., Tanaka K., Hypercytokinemia with 2009 pandemic H1N1 (pH1N1) influenza successfully treated with polymyxin B-immobilized fiber column hemoperfusion. Intensive Care Medicine 2010 36 5 906 907 2-s2.0-77951206273 10.1007/s00134-010-1830-8
90. Totsugawa T., Kuinose M., Yoshitaka H., Tsushima Y., Ishida A., Chikazawa G., Katayama K., Hiraoka A., Intraoperative direct hemoperfusion with a polymyxin-B immobilized fiber column for treatment of infective endocarditis. General Thoracic and Cardiovascular Surgery 2011 59 2 98 104 2-s2.0-79954439518 10.1007/s11748-010-0700-1
91. Wesche-Soldato D. E., Swan R. Z., Chung C.-S., Ayala A., The apoptotic pathway as a therapeutic target in sepsis. Current Drug Targets 2007 8 4 493 500 2-s2.0-34247632571 10.2174/138945007780362764 (Pubitemid 46672616)
92. Hotchkiss R. S., Swanson P. E., Freeman B. D., Tinsley K. W., Cobb J. P., Matuschak G. M., Buchman T. G., Karl I. E., Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Critical Care Medicine 1999 27 7 1230 1251 2-s2.0-0032770246 10.1097/00003246-199907000-00002 (Pubitemid 29379358)
93. Jo S. K., Cha D. R., Cho W. Y., Kim H. K., Chang K. H., Yun S. Y., Won N. H., Inflammatory cytokines and lipopolysaccharide induce fas-mediated apoptosis in renal tubular cells. Nephron 2002 91 3 406 415 2-s2.0-0036654765 10.1159/000064280 (Pubitemid 34765238)
94. Cantaluppi V., Assenzio B., Pasero D., Romanazzi G. M., Pacitti A., Lanfranco G., Puntorieri V., Martin E. L., Mascia L., Monti G., Casella G., Segoloni G. P., Camussi G., Ranieri V. M., Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Medicine 2008 34 9 1638 1645 2-s2.0-49749097851 10.1007/s00134-008-1124-6
95. Yatera K., Yamasaki K., Kawanami T., Tokuyama S., Ogoshi T., Kouzaki M., Nagata S., Nishida C., Yoshii C., Mukae H., A case of successful treatment with polymyxin B-immobilized fiber column direct hemoperfusion in acute respiratory distress syndrome after influenza A infection. Internal Medicine 2011 50 6 601 605 2-s2.0-84857093658
96. Yokoyama T., Tsushima K., Yamamoto H., Ito M., Agatsuma T., Kozumi T., Kubo K., Polymyxin B-immobilized fiber column hemoperfusion treatment for drug-induced severe respiratory failure: report of three cases. Internal Medicine 2010 49 1 59 64 2-s2.0-74549128552 10.2169/internalmedicine.49.2213
97. Sato N., Kojima K., Horio Y., Goto E., Masunaga A., Ichiyasu H., Kohrogi H., Successful treatment of severe amiodarone pulmonary toxicity with polymyxin B-immobilized fiber column direct hemoperfusion. Chest 2013 143 1146 1150
98. Ichiyasu H., Horio Y., Tsumura S., Hirosako S., Sakamoto Y., Sakata S., Nakashima K., Komatsu T., Kojima K., Masunaga A., Fujii K., Saita N., Kohrogi H., Favorable outcome with hemoperfusion of polymyxin B-immobilized fiber column for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis: report of three cases. Modern Rheumatology. In press
99. Seo Y., Abe S., Kurahara M., Okada D., Saito Y., Usuki J., Azuma A., Koizumi K., Kudoh S., Beneficial effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on acute exacerbation of idiopathic pulmonary fibrosis. Internal Medicine 2006 45 18 1033 1038 2-s2.0-33750332621 10.2169/internalmedicine.45.6018 (Pubitemid 44613581)
100. Tsushima K., Kubo K., Koizumi T., Yamamoto H., Fujimoto K., Hora K., Kan-Nou Y., Direct hemoperfusion using a polymyxin B immobilized column improves acute respiratory distress syndrome. Journal of Clinical Apheresis 2002 17 2 97 102 2-s2.0-0036328139 10.1002/jca.10019 (Pubitemid 34809559)
101. Abe S., Seo Y., Hayashi H., Matsuda K., Usuki J., Azuma A., Kudoh S., Gemma A., Neutrophil adsorption by polymyxin b-immobilized fiber column for acute exacerbation in patients with interstitial pneumonia: a pilot study. Blood Purification 2010 29 4 321 326 2-s2.0-77954065967 10.1159/000287232
102. Kikkawa T., Sato N., Kojika M., Takahashi G., Aoki K., Hoshikawa K., Akitomi S., Shozushima T., Suzuki K., Wakabayashi G., Endo S., Significance of Measuring S100A12 and sRAGE in the Serum of Sepsis Patients with Postoperative Acute Lung Injury. Digestive Surgery 2010 27 4 307 312 2-s2.0-77955120521 10.1159/000313687
103. 2 ratio following PMX-DHP therapy for postoperative septic shock. European Surgical Research 2011 47 3 135 140 2-s2.0-80052659576 10.1159/000330448